# Scandium International Mining Corp.: financial statements, quarterly

SCYYF · OTC · CIK 1408146 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/scyyf.md) · [Financials](/companies/scyyf/financials.md) · [Filings](/companies/scyyf/filings.md) · [Insiders](/companies/scyyf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/scyyf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(205) d](/filings/0001654954-22-003025.md) | [(251)](/filings/0001654954-22-006974.md) | [(174)](/filings/0001654954-22-010953.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(215)](/filings/0001654954-22-015016.md) | [523](/filings/0001437749-23-031898.md) | [28.6](/filings/0001437749-23-031898.md) | [70.7](/filings/0001437749-23-031898.md) | [228](/filings/0001437749-23-031898.md) | [236](/filings/0001437749-24-034770.md) | [(130)](/filings/0001437749-24-034770.md) | [74.7](/filings/0001437749-24-034770.md) | [(134)](/filings/0001437749-24-034770.md) | [(151)](/filings/0001437749-24-034770.md) | [(4.3)](/filings/0001437749-24-034770.md) | [(79.6)](/filings/0001437749-24-034770.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | [0.00](/filings/0001437749-23-023018.md) | [0.00](/filings/0001437749-23-031898.md) | not reported | [0.00](/filings/0001437749-24-016988.md) | [0.00](/filings/0001437749-24-026676.md) | [0.00](/filings/0001437749-24-034770.md) | not reported | [0.00](/filings/0001437749-24-016988.md) | [0.00](/filings/0001437749-24-026676.md) | [0.00](/filings/0001437749-24-034770.md) |

- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | [93.9](/filings/0001654954-23-002495.md) | [46.9](/filings/0001654954-22-006974.md) | [2,314](/filings/0001654954-22-010953.md) | not reported | [1,853](/filings/0001437749-24-010242.md) | not reported | [1,361](/filings/0001437749-23-023018.md) | [1,135](/filings/0001437749-23-031898.md) | [1,022](/filings/0001437749-24-034770.md) | [908](/filings/0001437749-24-016988.md) | [801](/filings/0001437749-24-026676.md) | [718](/filings/0001437749-24-034770.md) |
| Current assets | $k | [129](/filings/0001654954-23-002495.md) | [74.4](/filings/0001654954-22-006974.md) | [2,334](/filings/0001654954-22-010953.md) | [1,982](/filings/0001654954-22-015016.md) | [1,886](/filings/0001437749-24-010242.md) | [1,581](/filings/0001654954-23-006314.md) | [1,398](/filings/0001437749-23-023018.md) | [1,156](/filings/0001437749-23-031898.md) | [1,062](/filings/0001437749-24-034770.md) | [936](/filings/0001437749-24-016988.md) | [821](/filings/0001437749-24-026676.md) | [732](/filings/0001437749-24-034770.md) |
| Total assets | $k | [847](/filings/0001654954-23-002495.md) | [792](/filings/0001654954-22-006974.md) | [3,049](/filings/0001654954-22-010953.md) | [2,696](/filings/0001654954-22-015016.md) | [2,601](/filings/0001437749-24-010242.md) | [2,293](/filings/0001654954-23-006314.md) | [2,113](/filings/0001437749-23-023018.md) | [1,870](/filings/0001437749-23-031898.md) | [1,777](/filings/0001437749-24-034770.md) | [1,651](/filings/0001437749-24-016988.md) | [1,536](/filings/0001437749-24-026676.md) | [1,447](/filings/0001437749-24-034770.md) |
| Current liabilities | $k | [1,728](/filings/0001654954-22-006974.md) | [732](/filings/0001654954-22-006974.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $k | [1,728](/filings/0001654954-23-002495.md) | [1,150](/filings/0001654954-22-006974.md) | [2,345](/filings/0001654954-22-010953.md) | [1,860](/filings/0001654954-22-015016.md) | [1,508](/filings/0001437749-24-010242.md) | [940](/filings/0001654954-23-006314.md) | [865](/filings/0001437749-23-023018.md) | [537](/filings/0001437749-23-031898.md) | [349](/filings/0001437749-24-034770.md) | [374](/filings/0001437749-24-016988.md) | [263](/filings/0001437749-24-026676.md) | [254](/filings/0001437749-24-034770.md) |
| Shareholders' equity | $k | [(880)](/filings/0001437749-24-010242.md) | [(357)](/filings/0001437749-23-031898.md) | [704](/filings/0001437749-23-031898.md) | [836](/filings/0001437749-23-031898.md) | [1,093](/filings/0001437749-24-034770.md) | [1,356](/filings/0001437749-24-034770.md) | [1,248](/filings/0001437749-24-034770.md) | [1,334](/filings/0001437749-24-034770.md) | [1,428](/filings/0001437749-24-034770.md) | [1,277](/filings/0001437749-24-034770.md) | [1,273](/filings/0001437749-24-034770.md) | [1,193](/filings/0001437749-24-034770.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(41.2) d](/filings/0001654954-23-002495.md) | [(47.0)](/filings/0001654954-23-006314.md) | [(459) d](/filings/0001437749-23-023018.md) | [(342) d](/filings/0001437749-23-031898.md) | [(99.3) d](/filings/0001437749-24-010242.md) | [(308)](/filings/0001437749-24-016988.md) | [(184) d](/filings/0001437749-24-026676.md) | [(226) d](/filings/0001437749-24-034770.md) | [(113) d](/filings/0001437749-24-010242.md) | [(114)](/filings/0001437749-24-016988.md) | [(108) d](/filings/0001437749-24-026676.md) | [(82.1) d](/filings/0001437749-24-034770.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

## Shares

| Line item | Unit | Q1 FY2018 (2018-03-31) | Q2 FY2018 (2018-06-30) | Q3 FY2018 (2018-09-30) | Q1 FY2019 (2019-03-31) | Q2 FY2019 (2019-06-30) | Q3 FY2019 (2019-09-30) | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [293](/filings/0001654954-19-007174.md) | [302](/filings/0001654954-19-009133.md) | [305](/filings/0001654954-19-012652.md) | [306](/filings/0001654954-20-005149.md) | [312](/filings/0001654954-20-008640.md) | [312](/filings/0001654954-20-012201.md) | [312](/filings/0001654954-21-005481.md) | [312](/filings/0001654954-21-008751.md) | [312](/filings/0001654954-21-011825.md) | [314](/filings/0001654954-21-005481.md) | [316](/filings/0001654954-21-008751.md) | [316](/filings/0001654954-21-011825.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 355,860,813 at 2024-11-13, from the cover of the [10-Q filed 2024-11-13](/filings/0001437749-24-034770.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.